Search Results 161-170 of 17173 for CLL

  1. Clinical trials - Hematology

    ... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...

  2. Diseases and Conditions that Start with C - Mayo Clinic

    CLL. See. Chronic lymphocytic leukemia. Clostridioides difficile infection. See. C. difficile infection. Clostridium difficile infection. See. C. difficile ...

  3. Rituximab (intravenous route) - Side effects & uses - Mayo Clinic

    Rituximab injection is used together with other medicines (eg, fludarabine cyclophosphamide) to treat chronic lymphocytic leukemia (CLL). Rituximab ...

  4. Hematology - Clinical trials

    A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).

  5. Hematology - Clinical trials

    A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).

  6. Cancer Clinical Trials - Medical Professionals

    A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small ...

  7. Macroglobulinemia Clinical Trials - Mayo Clinic Research

    ... (CLL), small lymphocytic lymphoma (SLL), or Non-Hodgkin's Lymphomas for ... chronic lymphocytic leukemia (CLL) or Waldenstrom's macroglobulinemia (WM).

  8. Cancer - 2011 Archives - Mayo Clinic News Network

    Vitamin D and CLL. July 26, 2011. Incontinence After Prostate Surgery. June 2, 2011. Genetic Testing for Breast Cancer. April 19, 2011. Colon Cancer Symptoms ...

  9. New Mayo Clinic studies to be presented at American Society of Hematology meeting

    Chronic lymphocytic leukemia is a type of cancer of the ... "This supports our hypothesis that the scores are significant predictors for CLL prognosis.

  10. Clinical trials - Oncology (Medical)

    A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).